Europe Medical Cannabis Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Medical Cannabis Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Medical Cannabis Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rise in approvals of medical cannabis and business expansion of companies are bolstering the medical cannabis market growth worldwide

5.2 Market Opportunities

5.2.1 Rising urge to control the COVID-19 pandemic is boosting the demand for medical cannabis, thereby providing opportunity for the medical cannabis market players.

5.3 Future Trends

5.3.1 Increasing distribution is expected to attract more investments and may lead to market growth during the forecast period.

5.4 Impact of Drivers and Restraints

6. Europe Medical Cannabis Market Regional Analysis

6.1 Europe Medical Cannabis Market Overview

6.2 Europe Medical Cannabis Market Revenue 2019-2028 (US$ Million)

6.3 Europe Medical Cannabis Market Forecast Analysis

7. Europe Medical Cannabis Market Analysis – by Product Type

7.1 Flowers

7.1.1 Overview
7.1.2 Flowers: Europe Medical Cannabis Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Concentrates

7.2.1 Overview
7.2.2 Concentrates: Europe Medical Cannabis Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Tablets

7.3.1 Overview
7.3.2 Tablets: Europe Medical Cannabis Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Cannabis Oil & Topical Ointments

7.4.1 Overview
7.4.2 Cannabis Oil & Topical Ointments: Europe Medical Cannabis Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Capsules

7.5.1 Overview
7.5.2 Capsules: Europe Medical Cannabis Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Beverages & Edibles

7.6.1 Overview
7.6.2 Beverages & Edibles: Europe Medical Cannabis Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Medical Cannabis Market Analysis – by Medical Application

8.1 Pain Management

8.1.1 Overview
8.1.2 Pain Management: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Neurological Health Management

8.2.1 Overview
8.2.2 Neurological Health Management: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Mental Health Management

8.3.1 Overview
8.3.2 Mental Health Management: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Medical Cannabis Market Analysis – by Compound

9.1 THC-Dominant

9.1.1 Overview
9.1.2 Mental Health Management: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

9.2 CBD-Dominant

9.2.1 Overview
9.2.2 Mental Health Management: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Balanced THC & CBD

9.3.1 Overview
9.3.2 Mental Health Management: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Medical Cannabis Market – Europe Analysis

10.1 Europe

10.1.1 Europe Medical Cannabis Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Medical Cannabis Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Medical Cannabis Market Breakdown, by Product Type
10.1.1.1.2 UK: Europe Medical Cannabis Market Breakdown, by Medical Application
10.1.1.1.3 UK: Europe Medical Cannabis Market Breakdown, by Compound

10.1.1.2 Germany: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Medical Cannabis Market Breakdown, by Product Type
10.1.1.2.2 Germany: Europe Medical Cannabis Market Breakdown, by Medical Application
10.1.1.2.3 Germany: Europe Medical Cannabis Market Breakdown, by Compound

10.1.1.3 France: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Medical Cannabis Market Breakdown, by Product Type
10.1.1.3.2 France: Europe Medical Cannabis Market Breakdown, by Medical Application
10.1.1.3.3 France: Europe Medical Cannabis Market Breakdown, by Compound

10.1.1.4 Russia: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Medical Cannabis Market Breakdown, by Product Type
10.1.1.4.2 Russia: Europe Medical Cannabis Market Breakdown, by Medical Application
10.1.1.4.3 Russia: Europe Medical Cannabis Market Breakdown, by Compound

10.1.1.5 Italy: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Medical Cannabis Market Breakdown, by Product Type
10.1.1.5.2 Italy: Europe Medical Cannabis Market Breakdown, by Medical Application
10.1.1.5.3 Italy: Europe Medical Cannabis Market Breakdown, by Compound

10.1.1.6 Rest of Europe: Europe Medical Cannabis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Medical Cannabis Market Breakdown, by Product Type
10.1.1.6.2 Rest of Europe: Europe Medical Cannabis Market Breakdown, by Medical Application
10.1.1.6.3 Rest of Europe: Europe Medical Cannabis Market Breakdown, by Compound

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Medical Cannabis Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Organigram Holdings Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Aurora Cannabis Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Cannabis Science, Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Canopy Growth Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Medical Marijuana Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 VIVO Cannabis Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Tikun Olam

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Tilray

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 The Cronos Group

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Canvory

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights